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Importance:Nodular melanoma (NM) is a rapidly pro-
gressing potentially lethal skin tumor for which early di-
agnosis is critical.
Objective:Todetermine the dermoscopy features ofNM.
Design: Eighty-three cases of NM, 134 of invasive non-
NM, 115 of nodular benignmelanocytic tumors, and 135
of nodular nonmelanocytic tumors were scored for der-
moscopy features using modified and previously de-
scribedmethods. Lesionswere separated into amelanotic/
hypomelanotic or pigmented to assess outcomes.
Setting: Predominantly hospital-based clinics from 5
continents.
Main Outcome Measures: Sensitivity, specificity,
and odds ratios for features/models for the diagnosis of
melanoma.
Results: Nodular melanoma occurred more frequently
as amelanotic/hypomelanotic (37.3%) than did invasive
non-NM (7.5%). Pigmented NM had a more frequent
(compared with invasive non-NM; in descending order
of odds ratio) symmetrical pigmentation pattern (5.8%
vs 0.8%), large-diameter vessels, areas of homogeneous
blue pigmentation, symmetrical shape, predominant pe-
ripheral vessels, blue-white veil, pink color, black color,
and milky red/pink areas. Pigmented NM less fre-
quently displayed an atypical broadened network, pig-
ment network or pseudonetwork,multiple blue-gray dots,
scarlike depigmentation, irregularly distributed and sized
brown dots and globules, tan color, irregularly shaped
depigmentation, and irregularly distributed and sized dots
and globules of any color. The most important positive
correlating features of pigmented NM vs nodular non-
melanoma were peripheral black dots/globules, mul-
tiple brown dots, irregular black dots/globules, blue-
white veil, homogeneous blue pigmentation, 5 to 6 colors,
and black color. A model to classify a lesion as melano-
cytic gave a high sensitivity (98.0%) for both nodular
pigmented and nonnodular pigmented melanoma but a
lower sensitivity for amelanotic/hypomelanoticNM(84%).
Amethod for diagnosing amelanotic/hypomelanotic ma-
lignant lesions (including basal cell carcinoma) gave a
93% sensitivity and 70% specificity for NM.
Conclusions and Relevance: When a progressively
growing, symmetrically patternedmelanocytic nodule is
identified, NM needs to be excluded.
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N ODULAR MELANOMA(NM) is defined as an in-vasive melanoma thatlacks significant intraepi-dermal tumor cells be-
yond the margins of the dermal invasive
component.1 Although NM constitutes
only 9% to 15% of invasive melanoma, it
is overrepresented as a cause of lethalmela-
noma. Nodular melanoma is themost fre-
quent subtype of thick, rapidly growing
melanomas (reviewed byChamberlain and
Ng2 and Kelly et al3), is frequently not di-
agnosed until it is at a locally advanced
stage, and therefore is associated with a
relatively poor prognosis. The lesions
present clinically as firm papules or nod-
ules, with more frequent ulceration and
less color variegation than other invasive
melanomas.Nodularmelanoma lesions are
more frequently light colored than the
other common melanoma subtypes. For
this reason, the well-known ABCD rule
(asymmetry, border irregularity, color vari-
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ability, and diameter 6 mm) for clinical diagnosis for
NM is less useful, and an EFG pneumonic of elevation,
firm consistency, and progressive growth to describe their
clinical presentation is more apt.3 In Australia, NM le-
sions are more commonly found in sun-damaged skin
of the head and neck region of elderly men.2
Unlike the extensive literature on the dermoscopy of
melanoma in general, there is a relative paucity of der-
moscopy literature on the subtype NM,4-6 withmany ob-
servations grouped with those of other invasive melano-
mas7 or small case series.8,9 In this study, we documented
the dermoscopy features of a large series of NM; we de-
scribe that here and validate criteria used for their der-
moscopic diagnosis.
METHODS
IMAGE ACQUISITION AND INCLUSION
AND EXCLUSION CRITERIA
Digital dermoscopic images of lesions taken with glass plate/
liquidnonpolarizedor cross-polarizedphotographic deviceswere
obtained from members of the International Dermoscopy So-
ciety from 5 continents. A request was made for images of all
NMs satisfying the inclusion criteria and for a random selec-
tion of nonnodular invasive primary melanoma, benign nodu-
lar melanocytic lesions, and nodular nonmelanocytic lesions
at a desired ratio of NM to other subgroups of 1:2.
All lesions obtained were excised and histopathologic ex-
amination was performed except for some benign melano-
cytic nevi that showed no change over time comparedwith base-
line photographs. Nodularmelanomawas defined as an invasive
melanoma without an in situ (junctional) component beyond
3 rete ridges of the dermal invasive component.1 The histo-
logic sections of all NM lesions were reviewed by a second pa-
thologist either at the institution of origin or by one of us (R.A.S.).
Lesions were included as “nodular” melanoma only when the
second review confirmed the diagnosis according to the his-
tologic definition used. Both nodular benign melanocytic le-
sions and nodular nonmelanocytic lesions were identified by
the clinical appearance of a solitary nodule and confirmed using
dermoscopic examination.
Images received were included, attempting to maintain the
desired ratio of 1:2 for nodular malignant melanoma (MM) to
other subtypes within individual centers (M.A.), and con-
firmed as morphologically nodular and correctly categorized
according to their histopathologic examination reports (P.G.
andM.A.). These dermoscopic images were reviewed (S.W.M.),
blinded to diagnosis and institution of origin, categorized by
their pigmentation type as previously reported,7 and excluded
if the image quality was poor. Amelanotic lesions were de-
fined as having no melanin pigmentation (ie, tan, dark brown,
blue, gray, or black) on dermoscopic examination. Tan pig-
mentation is defined as light brown pigmentation that is darker
than the surrounding skin. Two subgroups of hypomelanotic
lesions were defined. On dermoscopic evaluation, partially pig-
mented lesions have a melanin pigmentation area of less than
25% of the total surface area. Light-colored (slightly pig-
mented) lesions have only tan, light blue, or light gray pig-
mentation that may occupy more than 25% of the total surface
area; no dark brown, deep blue, or black pigmentation is found.
All lesions not categorized as amelanotic or hypomelanotic by
these definitions were defined as “pigmented.” The flowchart
of included lesions is shown in Figure 1.
The study consisted of 467 lesions; of these, 83 were NM,
134 were invasive non-NM, 115 were nodular benign melano-
cytic tumors, and 135 were nodular nonmelanocytic tumors.
Table 1 reports the frequency of each diagnosis, and Table 2
lists the frequency of eachmajor diagnostic category as a func-
tion of the overall dermoscopic pigmentation type.
All lesion images used in the study were obtained retro-
spectively from photographic libraries at various institutions,
and participants provided verbal or written consent for their
use. Formal ethics approval for the study was obtained at the
coordinating center (SydneyMelanomaDiagnostic Centre, Aus-
tralia). When relevant, institutional review board approval or
waiver at the individual external sites was sought.
DERMOSCOPIC FEATURES
The features included in the study were determined by con-
sensus of the members of the International Dermoscopy Soci-
ety. Before scoring, clinicians were given a morphologic tuto-
rial to define all vascular andmore recently defined structures.
The definitions of the features are as described previously.7
Twelve scorers blinded to the lesion diagnosis scored 99 indi-
vidual features in each lesion of approximately equal sample
sizes, as previously described.7 Following the review of the ar-
635 Dermoscopy lesion images of NM,
nonnondular invasive melanoma,
benign nodular melanocytic, and 
nodular nonmelanocytic lesions 
recruited from IDS members
168 Lesion images excluded because 
of lack of nodularity, exceeding the 
desired ratio of NM to other 
subtypes, or poor image quality
467 Dermoscopy lesion images; scorers 









Figure 1. Flowchart of included lesions. IDS indicates International
Dermoscopy Society; NM, nodular melanoma.
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ticle for publication, an additional feature (blue-black struc-
tures) was scored for all lesions by one observer (E.C.). First-
step dermoscopic analysis to define a melanocytic lesion was
scored separately (S.W.M.). This method10 was extended to al-
low the diagnosis of amelanotic or hypomelanotic melano-
cytic lesions. Hence, in this study, the extended method de-
fines a melanocytic lesion as diagnosed if 1 or more of pigment
network or pseudonetwork, aggregated brown or black glob-
ules, streaks (pseudopods or radial streaming), homogeneous
blue structureless pigmentation within the lesion, parallel pat-
tern (on volar sites), pinpoint (small dotted) vessels, or comma
vessels are found. In addition, if a lesion has no features of a
nonmelanocytic lesion, it is also defaulted as melanocytic. Sec-
ond-step analysis (to determine a diagnosis of melanoma) was
scored separately on all lesions using the ABCDmethod (with
a score 5.45 indicating melanoma)11 (M.C.), the Menzies
method12 (S.W.M.), 7-point checklist (with a score 3 indi-
catingmelanoma)13 (G.A. and I.Z.), 3-point checklist14 (D.C.G
and H.P.S.), CASH (color, architecture, symmetry, and homo-
geneity) score (with a score8 indicatingmelanoma)15 (F.J.M.),
and a high-sensitivitymodel for amelanotic/hypomelanoticma-
lignant lesions7 (S.W.M.).
STATISTICAL ANALYSIS
Commercial statistical software was used to analyze the data
(SPSS for Windows, version 18; SPSS Inc, and LogXact, ver-
sion 6; Cytel Inc). The exact permutation methods available
in the latter package were used when zero cell counts were ob-
served. Two-tailed tests with a significance level of 5% were
used throughout the analysis, and 2 tests (or Fisher exact test
when appropriate) were used to test for association between
the presence of a feature and lesion type. Odds ratios (ORs)
and their 95% CIs were used to quantify the level of associa-
tion. The sensitivity and specificity of each feature for the di-
agnosis of interest compared with other lesion types were ex-
pressed as percentages. TheMcNemar test was used to compare
the predicted lesion status according to different diagnosticmeth-
ods within various subgroups of patients.
RESULTS
GENERAL TUMOR CHARACTERISTICS
The diagnostic categories of the study lesions are sum-
marized in Table 1. Themedian Breslow thickness of NM
(2.7 mm) was significantly greater than that of the non-
nodular invasive melanoma (0.7 mm) (P  .001, Mann-
Whitney test). The pigmentation category of tumors
(amelanotic, partial pigmented, light colored, and pig-
mented) differed significantly as a function of diagnosis
(P .001, Fisher exact test) (Table 2). In particular, NM
was less frequently pigmented (62.7%) than nonnodu-
lar invasivemelanoma (92.5%) butmore pigmented than
nodular nonmelanocytic lesions (46.7%) (P .001, Fisher
exact test). For this reason, when comparing the 4 broad
diagnostic categories of tumors, analyses were always
stratified according to pigmentation type.
DERMOSCOPIC FEATURES OF PIGMENTED
NODULAR VS NONNODULAR
INVASIVE MELANOMA
When analyzing only pigmented tumors, NM was more
frequently (compared with nonnodular invasive mela-
noma; in descending order of OR) found to have a sym-
metrical pigmentation pattern (5.8% vs 0.8%), large-
diameter vessels, areas of homogeneous bluepigmentation,
symmetrical shape, predominant peripheral vessels, blue-
white veil, pink color, black color, andmilky red/pink areas
(Table 3). Pigmented NM less frequently (in ascending
order of OR compared with nonnodular invasive mela-
noma) displayed an atypical broadened network, pig-
ment network or pseudonetwork,multiple blue-gray dots
(granularity), scarlike depigmentation, irregularly distrib-
uted and sized brown dots and globules, tan color, irregu-
larly shaped depigmentation, and irregularly distributed
and sized dots and globules. Because of the limited sample
size of nonpigmented non-NM(n = 10), a comparison be-
tween nonpigmented melanoma is not reported.
DERMOSCOPIC FEATURES OF NM
VS NODULAR NONMELANOMA
Table 4 reports the univariable analysis of the signifi-
cant dermoscopic features found in pigmentedNM com-
pared with all pigmented nodular nonmelanomas. The
negative correlating features related to those found in
nodular pigmented basal cell carcinoma (arborizing ves-
sels, leaflike areas, large blue-gray ovoid nests, andmul-
tiple blue-gray globules), which were all absent in NM,
were features found in seborrheic keratoses (millialike
cysts, comedolike openings/irregular crypts) and fea-
tures found in benign melanocytic lesions (regular size
and distributed dots/globules, symmetrical pigmenta-
tion pattern). Regularly shaped and sized vessels were
also a negative correlating feature ofmelanoma. Themost








NM 52 (62.7) 8 (9.6) 14 (16.9) 8 (9.6) 1 (1.2) 83 (100.0)
Nonnodular invasive melanoma 124 (92.5) 3 (2.2) 5 (3.7) 2 (1.5) 0 134 (100.0)
Nodular benign melanocytic lesion 75 (65.2) 11 (9.6) 7 (6.1) 22 (19.1) 0 115 (100.0)
Nodular nonmelanocytic lesion 63 (46.7) 31 (23.0) 10 (7.4) 18 (13.3) 13 (9.6) 135 (100.0)
Abbreviation: NM, nodular melanoma.
aA total of 467 study lesions were obtained (see the Methods section for the inclusion criteria). The pigmentation category of tumors differed significantly as a
function of diagnosis (P  .001, Fisher exact test).
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important positive correlating features of NM were (in
order of OR) peripheral black dots/globules, multiple
browndots, irregular black dots/globules, blue-white veil,
pseudopods, homogeneous blue pigmentation, 5 to 6 col-
ors, black color, irregular blotches (black, brown, or gray),
irregularly sized and distributed dots/globules, blue-
black structures, central black dots/globules, atypical vas-
cular pattern (linear irregular or dotted vessels not clearly
seenwithin regression structures), dark brown color, and
milky red-pink areas.
Table 5 reports the univariable analysis of the sig-
nificant dermoscopic features found in amelanotic/
hypomelanotic NM compared with all amelanotic/
hypomelanotic nodular nonmelanomas. The negative
correlating features were symmetrical pigmentation pat-
tern, which was significantly more frequent in both be-
nign melanocytic and nonmelanocytic lesions com-
pared with melanoma; arborizing vessels (presence,
predominance, and small diameter); regular comma ves-
sels; a single color; and symmetrical shape. Themost im-
portant positive correlating features, in order of OR, were
blue-white veil, atypical vascular pattern (linear irregu-
lar or dotted vessels not clearly seen within regression
structures), homogeneous blue pigmentation, 5 to 6 col-
ors, black color, centralwhite patch, blue color,more than
1 shade of pink, predominant linear irregular vessels, ir-
regular black dots/globules, milky red-pink areas, irregu-
lar depigmentation, black or brown globules, irregular
blotches, milky red globules, irregular dots/globules, and
hairpin vessels.
There were no significant differences between the fre-
quency of ulceration inNMvs nonnodular invasivemela-
nomaor nodular nonmelanomas; however, ulcerationwas
significantly decreased in NMs (14.5% [12 of 83 le-
sions]) compared with nodular basal cell carcinomas
(35.5% [22 of 62]) (P = .003, 2).
TWO-STEP PROCEDURE FOR DIAGNOSIS OF NM
We tested a revised first-step procedure (see the Meth-
ods section, Dermoscopic Features subsection) to clas-
sify a lesion asmelanocytic vs nonmelanocytic (Table6).
The method had a high sensitivity (98%) for correctly
classifying nodular pigmented and nonnodular pig-
mentedmelanoma asmelanocytic lesions. However, there
was a significant decrease in the sensitivity for amelanotic/
hypomelanotic NM (84%) and non-NM (50%) com-
pared with their pigmented counterparts.
We tested previously described second-step methods
for the diagnosis of melanoma for pigmented melano-
cytic lesions (Table 7). When comparing the sensitiv-
ity for the diagnosis of NM vs non-NM within indi-
vidual methods, we found significantly decreased
sensitivity for NM with the 7-point checklist (P = .02),
a borderline but nonsignificant decrease with the Men-
ziesmethod (P = .06), but no significant differencewithin
the other methods (ABCD, P = .92; CASH, P = .42; and
3-point, P = .62). The highest sensitivity for pigmented
NM was 92.3% (Menzies method), although this was at
the expense of a relatively lower specificity comparedwith
most other methods. Figure 2 shows typical examples
of pigmented NM lesions that were confirmed with all
diagnostic methods. Figure 3 shows examples of pig-
mented NM lesions that were misclassified with most
methods. The hallmark of the latter was the symmetri-
cal pigment pattern, which is more frequently found in
pigmented nodular (5.8%) vs nonnodular (0.8%) inva-
sive melanoma.
We assessed the high-sensitivitymethod described for
the diagnosis of amelanotic/hypomelanoticmalignant le-
sions7 on all amelanotic/hypomelanotic lesions. In the
model with melanoma diagnosed with a score of 1 or
more, the sensitivity for the diagnosis of NM was 93%
Table 3. Dermoscopic Features of Pigmented Nodular vs Pigmented Nonnodular Invasive Melanoma
Feature
Melanoma, %
P Value OR (95% CI)Nodular Nonnodular
Positive features
Symmetrical pigmentation pattern 5.8 0.8 .045 7.6 (0.8-75.6)
Large-diameter vesselsa 5.8 0.8 .04 7.6 (0.8-75.6)
Homogeneous blue pigmentation within lesion 80.8 43.1 .001 5.6 (2.6-12.1)
Symmetrical shape 32.7 11.3 .001 3.8 (1.7-8.5)
Predominant peripheral vessels 25.0 8.1 .02 3.8 (1.5-9.3)
Blue-white veil 84.6 62.6 .004 3.3 (1.4-7.6)
Pink color 48.1 29.0 .02 2.3 (1.2-4.4)
Black color 75.0 56.5 .02 2.3 (1.1-4.8)
Milky red/pink areas 34.6 19.4 .03 2.2 (1.1-4.5)
Negative features
Atypical network (broadened and irregular) 3.8 32.5 .001 0.08 (0.02-0.36)
Pigment network/pseudonetwork 11.5 58.5 .001 0.09 (0.04-0.23)
Multiple blue-gray dots (granularity) 3.8 14.6 .04 0.23 (0.05-1.04)
Scarlike depigmentation 17.3 45.5 .001 0.25 (0.11-0.56)
Irregular brown dots/globules 40.4 65.3 .002 0.36 (0.19-0.70)
Tan color 42.3 66.9 .002 0.36 (0.19-0.71)
Irregular shape depigmentation 15.4 33.1 .02 0.37 (0.16-0.85)
Irregular dots/globules of any color 42.3 59.7 .04 0.49 (0.26-0.95)
Abbreviation: OR, odds ratio.
aLinear (horizontal) vessels with a caliber diameter at least 3 times that of the neighboring thinnest-caliber (small-diameter) vessels.
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and the score for nonnodular invasivemelanomawas 90%.
The specificity for benign nodular melanocytic lesions
was 70%. When the threshold was reduced with mela-
noma diagnosed at a score of 0 or more, 100% sensitiv-
ity for the diagnosis of both nodular and non-NM was
achieved but with a relatively low specificity of 52.5%
for benign nodular melanocytic lesions. Figure 4 shows
examples of amelanotic/hypomelanotic NM.
COMMENT
Consistentwith the literature,16 in our seriesNMwasmore
frequently amelanotic/hypomelanotic (37.3%) than was
invasive non-NM (7.5%). Furthermore, our study de-
pended on the clinician to image a lesion before exci-
sion. Nonpigmented NM may not be clinically sus-
pected to be melanoma; hence, it is conceivable that
images may be taken less frequently compared with the
pigmented variety. As with other subtypes of mela-
noma, the dermoscopy features of hypomelanotic mela-
noma are very different from those of the pigmented va-
riety. For this reason, the diagnostic approach for
hypomelanotic and pigmented NM should be separate.
In our study, 5.8% of pigmented NM showed sym-
metry of pigmentation pattern across all axes. In con-
trast, only 0.8% of invasive pigmented non-NM showed
symmetry of pattern. Our results are consistent with lim-
ited data previously published. In a series of 10 NM le-
sions, all showed an asymmetrical pigmentation pattern
under dermoscopy examination.6 In a study of thin and
Table 4. Univariable Analysis of Pigmented NM vs All Pigmented Nodular Nonmelanoma
Feature Sensitivity, %a Specificity, %b P Value OR (95% CI)
Negative
Arborizing vessels 0 91.3 .04 0 (0 to 0.91)
Arborizing vessels, small diameter 0 92.8 .08 0 (0 to 1.15)
Leaflike areas 0 92.7 .08 0 (0 to 1.15)
Large blue-gray ovoid nests 0 89.9 .02 0 (0 to 0.75)
Multiple blue-gray globules 0 90.5 .03 0 (0 to 0.83)
Regular dots/globules (size and distribution; any color) 0 84.8 .002 0 (0 to 0.46)
Multiple (3) milialike cysts 1.9 81.1 .003 0.08 (0.01 to 0.64)
Comedolike openings (irregular crypts) 1.9 81.2 .003 0.08 (0.01 to 0.64)
Regular vessels (uniform shape/size)c 1.9 83.3 .01 0.10 (0.01 to 0.75)
1-3 Milialike cysts 3.8 85.5 .04 0.23 (0.05 to 1.04)
Symmetrical pigmentation pattern 5.8 79.9 .02 0.25 (0.07 to 0.84)
Regular brown dots/globules 5.8 81.1 .03 0.27 (0.08 to 0.91)
Positive
Peripheral black dots/globulesc 17.3 99.3 .001 28.43 (3.5 to 229.1)
Multiple brown dotsc 7.7 100.0 .01 14.90 (1.8 to 100)
Irregular black dots/globulesc 50.0 93.5 .001 14.29 (6.0 to 34.0)
Blue-white veilc 84.6 69.8 .001 12.68 (5.5 to 29.3)
Pseudopods 7.7 99.3 .01 11.34 (1.3 to 103.2)
Homogeneous blue pigmentationc 80.8 72.0 .001 10.81 (4.9 to 23.7)
5-6 Colorsc,d 57.7 87.7 .001 9.74 (4.6 to 20.6)
Black colorc 75.0 75.3 .001 9.16 (4.4 to 19.2)
Irregular blotches (black, brown, or gray) 46.2 91.3 .001 9.02 (4.0 to 20.2)
Irregular dots/globules (size and/or distribution; any color)c 59.6 84.1 .001 7.80 (3.8 to 16.0)
Blue-black structuresc 51.9 87.0 .001 7.20 (3.4 to 15.0)
Central black dots/globulesc 17.3 97.1 .001 7.05 (2.1 to 24.1)
Atypical vascular patternc,e 38.5 91.3 .001 6.56 (2.9 to 14.8)
Dark brown colorc 75.0 60.9 .001 4.66 (2.3 to 9.5)
Milky red/pink areas 34.6 88.4 .001 4.05 (1.9 to 8.8)
Streaks (pseudopods/radial streaming) 9.6 97.2 .05 3.62 (0.9 to 14.1)
Milky red globules 13.5 95.7 .03 3.44 (1.1 to 10.8)
Linear irregular vessels, predominant type 28.8 89.1 .002 3.32 (1.5 to 7.4)
Irregular brown dots/globulesc 40.4 82.6 .001 3.22 (1.6 to 6.5)
Blue color 73.1 51.5 .002 2.88 (1.4 to 5.8)
Red-blue color 32.7 84.8 .01 2.70 (1.3 to 5.7)
Linear irregular vessels 28.8 86.2 .0 2.54 (1.2 to 5.5)
Blurred “out of focus” colors 69.2 50.7 .01 2.31 (1.2 to 4.6)
Abrupt edge (any aspect)c 63.5 56.5 .01 2.26 (1.2 to 4.4)
Asymmetrical shape 55.8 63.0 .02 2.15 (1.1 to 4.1)
Pink color 48.1 69.6 .02 2.12 (1.1 to 4.1)
Abbreviations: NM, nodular melanoma; OR, odds ratio.
aThe percentage of NM lesions with that feature.
bThe percentage of nonmelanoma lesions without that feature.
c Indicates features that are significant with the same OR trend (ie, either all 1 or all 1) in both benign melanocytic and nonmelanocytic lesions compared
with melanoma.
dColors scored are tan, dark brown, black, blue, gray, and red.
eLinear irregular or dotted vessels not clearly seen within regression structures.
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small-diameterNM, although7of 11 tumors showed clini-
cal symmetry of pigmentation pattern, 9 of 11were asym-
metrical in pigmentation pattern under dermoscopy.5 Al-
though the frequency is relatively low, symmetry of
pigmentation pattern can occur in NM and is an impor-
tant reason for misdiagnosis using standard dermos-
copy methods.
Comparedwith nonnodular invasive pigmentedmela-
noma, pigmented NM lesions were more symmetrical in
pattern and shape, had large-diameter vessels and a greater
proportion of lesions with a predominance of periph-
eral vessels, had increased areas of homogeneous blue
pigmentation and blue-white veil, and had increased areas
of black and pink color (includingmilky red/pink areas).
Less frequently observed characteristics of NM in-
cluded classic patterns ofmelanoma, such as pigment net-
work (both typical and atypical), areas of regression (mul-
tiple blue-gray dots, irregularly shaped or scarlike
depigmentation), tan color, and irregularly shaped and
distributed brown dots and globules.
Black dots and globules are an important diagnostic
feature of pigmentedNM.These represent localizedmela-
nin accumulation (often melanoma cells) in the stratum
corneum17,18 or areas associated with nests of melano-
cytes just beneath the very thinned epidermis shortly be-
fore rupture or when already ulcerated (personal com-
munication, Caterina Longo,MD, PhD, SkinCancerUnit,
Areispedale S. Maria Nuova–Istituto di Ricovero e Cura
a Carattere Scientifico, Reggio Emilia, Italy; April 16,
2012). Peripheral black dots/globules had the highest OR
of any single dermoscopy feature for pigmentedNM (OR,
28), with irregular size and irregularly distributed black
dots/globules (OR, 14) and central black dots/globules
(OR, 7) also being important features. Multiple brown
dots, which are seen as aggregations of well-defined dark
brown dots and represent suprabasal intraepidermal col-
Table 5. Univariable Analysis of Amelanotic/Hypomelanotic NM vs All Amelanotic/Hypomelanotic Nodular Nonmelanoma
Feature Sensitivity, %a Specificity, %b P Value OR (95% CI)
Negative
Symmetrical pigmentation patternc 3.2 69.2 .002 0.07 (0.01-0.57)
Arborizing vessels 3.2 79.4 .02 0.13 (0.02-1.0)
Predominant arborizing vessels 3.2 77.7 .02 0.12 (0.01-0.89)
Regular comma vessels 3.2 81.2 .03 0.14 (0.02- 1.1)
Arborizing vessels, small diameter 3.2 81.2 .03 0.14 (0.02-1.1)
Single color 12.9 68.4 .04 0.32 (0.10-0.99)
Symmetrical shape 35.5 42.0 .03 0.40 (0.17-0.91)
Positive
Blue-white veilc 38.7 99.1 .001 67.4 (8.6-529.4)
Atypical vascular patternc,d 83.9 84.8 .001 29.1 (9.8-86.4)
Homogeneous blue pigmentationc 29.0 97.3 .001 14.4 (3.7-57.0)
5-6 Colorsc,e 9.7 99.1 .01 11.8 (1.2-117.2)
Black colorc 19.4 97.3 .001 8.7 (2.0-37.1)
Central white patch 12.9 98.2 .01 8.1 (1.4-46.5)
Blue colorc 48.4 88.4 .001 7.1 (2.9-17.7)
1 Shade of pinkc 61.3 80.3 .001 6.5 (2.7-15.3)
Predominant linear irregular vesselsc 51.6 85.7 .001 6.4 (2.7-15.4)
Irregular black dots/globules 9.7 98.2 .03 5.9 (0.9-36.8)
Milky red/pink areasc 45.2 86.6 .001 5.3 (2.2-13.0)
Irregular depigmentation 16.1 96.4 .01 5.2 (1.3-20.7)
Black or brown globules 16.1 96.4 .01 5.1 (1.3-20.3)
Irregular blotches (black, brown, or gray) 19.4 95.5 .01 5.1 (1.5-18.1)
Milky red globules 32.3 90.2 .002 4.4 (1.6-11.6)
Irregular dots/globules 19.4 94.6 .01 4.3 (1.3-14.3)
Hairpin vesselsc 29.0 91.1 .004 4.2 (1.5-11.5)
Scarlike depigmentation 12.9 96.4 .047 3.9 (0.9-16.7)
Linear irregular vessels 48.4 79.4 .002 3.6 (1.6-8.4)
Irregular brown dots/globules 19.4 93.8 .02 3.6 (1.1-11.7)
Peripheral hairpin vessels 19.4 92.9 .04 3.1 (1.0-9.9)
Predominant peripheral vessels 45.2 77.7 .01 2.9 (1.2-6.6)
Gray color 32.3 85.7 .02 2.9 (1.1-7.2)
Red-blue color 29.0 87.5 .03 2.9 (1.1-7.4)
Tan color 64.5 59.8 .02 2.7 (1.2-6.2)
Small dotted vessels 29.0 86.4 .04 2.6 (1.0-6.7)
Irregular vessels 58.1 64.3 .02 2.5 (1.1-5.6)
White color 45.2 74.1 .04 2.4 (1.0-5.4)
Abbreviations: NM, nodular melanoma; OR, odds ratio.
aThe percentage of NM lesions with that feature.
bThe percentage of nonmelanoma lesions without that feature.
c Indicates features that are significant with the same OR trend (ie, either all 1 or all 1) in both benign melanocytic and nonmelanocytic lesions compared
with melanoma.
dLinear irregular or dotted vessels not clearly seen within regression structures.
eColors scored are tan, dark brown, black, blue, gray, and red.
JAMA DERMATOL/VOL 149 (NO. 6), JUNE 2013 WWW.JAMADERM.COM
704
©2013 American Medical Association. All rights reserved.
Downloaded From: https://archderm.jamanetwork.com/ by Rory  Jackson on 10/12/2015
lections of melanin (usually melanoma cells),18 was also
an important diagnostic feature (OR, 15). This suggests
significant focal areas of intraepidermal pagetoid inva-
sion of melanoma cells in NM. According to Elder and
Murphy,19 the epidermis in NM is usually involved by
cells similar to those in the dermal tumor, and these cells
usually extend upward in a typical pagetoid pattern. Con-
sistent with this, in our study, there was no significant
difference in any of the dermoscopy features that histo-
pathologically correlated with pagetoid spread in pig-
mented nodular vs non-NM. In contrast, although lim-
ited studies of in vivo confocalmicroscopy ofNMconfirm
the presence of pagetoid cells, a trend to a less-
moderate infiltration of these cells was seen compared
with non-NM.6
Consistentwith the importance of black dots and glob-
ules, recently a large series of invasivemelanoma that pre-
sented as pigmented nodules with either no or a mini-
mal flat component was examined for the recently
described dermoscopy feature of blue-black structures.4
This feature, defined as the presence of a combination
of blue and black pigmented areas involving at least 10%
of the lesion surface, had a sensitivity of 78.2% and a speci-
ficity of 80.5% for the diagnosis of melanoma. We con-
firmed this observation in the present study, with blue-
black structures significantly increased in pigmentedNM
compared with pigmented nodular nonmelanoma (sen-
sitivity, 51.9%, and specificity, 87%).
It has been suggested that the vascular morphology
is dependent on the tumor volume and thickness inmela-
noma.20 In a study of amelanotic/hypomelanotic mela-
noma,7 thicker tumors had an increased prevalence of all
vessels, greater prevalence of pink color, and more hair-
pin and large-diameter–type vessels. Dotted/pinpoint ves-
Table 6. Modified First-Step Method to Determine Whether a Lesion Is Melanocytic
Lesion Characteristic
MM Sensitivity, %
Benign Nodular Melanocytic Sensitivity, % Nodular Nonmelanocytic Specificity, %aNodular Nonnodular
Pigmented 98.1b,c 99.2d,e 94.7 61.9
Amelanotic/hypomelanotic 83.9f 50.0g 87.5 75.0
Abbreviation: MM, malignant melanoma.
aThe specificity equals 100 minus the percentage of lesions falsely diagnosed as melanocytic.
bThere was a significant increase in the sensitivity of pigmented vs amelanotic/hypomelanotic lesions (P = .02, 2 test).
cThe solitary nodular MM lesion misclassified as nonmelanocytic had features of pigmented basal cell carcinoma (BCC).
dThere was a significant increase in the sensitivity of pigmented vs amelanotic/hypomelanotic lesions (P  .001, Fisher exact test).
eThe solitary nonnodular MM lesion misclassified as nonmelanocytic had features of pigmented BCC.
fFour of 5 of the nodular MM lesions misclassified as nonmelanocytic had features of BCC, and 1 had features of seborrheic keratosis.
gAll 5 of the nonnodular MM lesions misclassified as nonmelanocytic had features of pigmented BCC.
Table 7. Pairwise Comparisons of Sensitivity or Specificity Between Second-Step Methods for the Diagnosis of Pigmented Melanoma
Method Sensitivity, %b Specificity, %
P Valuea
CASH ABCD 7-Point 3-Point
NM
Menzies 92.3 . . . .02 .03 .06 .07
CASH 78.8 . . . .99 .75 .99
ABCD 80.8 . . . .99 .99
7-Point 82.7 . . . .99
3-Point 80.8 . . .
Non-NM
Menzies 98.4 . . . .001 .001 .12 .001
CASH 83.9 . . . .65 .004 .99
ABCD 81.5 . . . .001 .68
7-Point 94.4 . . . .004
3-Point 83.9 . . .
Benign Melanocytic Lesion
Menzies . . . 65.3 .42 .66 .08 .001
CASH . . . 72.0 .82 .33 .001
ABCD . . . 69.3 .14 .001
7-Point . . . 78.7 .001
3-Point . . . 40.0
Abbreviations: ABCD, ABCD rule of dermoscopy; CASH, color, architecture, symmetry, and homogeneity; ellipses, sensitivity relates to the melanoma lesions
and specificity relates to the benign lesions; NM, nodular melanoma.
aP values from the McNemar test of within-patient comparisons of predicted melanoma.
bWhen comparing the sensitivity for the diagnosis of NM vs non-NM within individual methods, there was a significantly decreased sensitivity for NM with the
7-point checklist (P = .02) and a borderline but nonsignificant decrease for the Menzies method (P = .06) but no significant difference within the other methods
(ABCD, P = .92; CASH, P = .42; and 3-point, P = .62).
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sels were less frequently found as the predominant ves-
sel type in thicker tumors. Consistent with this, in our
study, when comparing nodular and other invasivemela-
noma (which were significantly thinner), NM had an in-
creased prevalence of large-diameter vessels, pink color,
and milky red/pink areas.
Thirteen percent of our amelanotic/hypomelanoticNM
lesions were reported to have a central white patch. Such
patches are common in dermatofibroma21; however, the
findings of our study suggest that when they are present,
other features indicating malignancy should be care-
fully sought. Vascular patterns are clearly important in
distinguishing amelanotic/hypomelanoticNM fromnodu-
lar nonmelanomas. Nodularmelanoma uncommonly has
arborizing or regular comma vessels (3.2%). In con-
trast, NM lesions exhibit an atypical vascular pattern,with
themost important single vascular structures being a pre-
dominance of linear irregular vessels and the presence
of hairpin vessels. Milky red/pink areas, also indicating
greater angiogenesis, are an important feature of amela-
notic/hypomelanotic NM.
In a previously reported large series of amelanotic/
hypomelanoticmelanoma, themost important single vas-
cular feature of melanoma was the predominance of cen-
trally positionedvessels.7 In contrast, our study showed that
amelanotic/hypomelanotic NMhad a significantly greater
proportion of lesionswith vessels positioned in a predomi-
nantly peripheral position.However, this is consistentwith
the former study’s7 findings that thickmelanomas (1mm
Breslow thickness) had twice the frequency of peripheral
vessels as thin melanomas (0.75 mm).
Themedian Breslow thickness of our series of NMwas
2.7 mm. Because NM has a greater vertical growth rate
than other melanoma subtypes,22 it is rare to image NM
lesions as thinner small papules, which they presum-
ably are on first appearance. A small series of relatively
thin (1.3 mm) NM has been reported.5 Nine of 11 le-
sions were asymmetrical in pigmentation pattern, and
many had specific features of melanoma, including blue-
white veil and atypical vessels. Nevertheless, it remains






Figure 2. Typical nodular pigmented melanoma. A, This asymmetrical pigmented nodule has the significant positive predictors of blue-white veil, multiple (5-6)
colors (scored from tan, dark brown, red, blue, gray, and black), irregular blotches, irregular brown dots and globules, and black color (Breslow thickness, 4.5
mm). B, This asymmetrical pigmented nodule has a blue-white veil, irregular blotches, and irregular dots and globules, some of which are black, that are found
both in a central and peripheral position (Breslow thickness, 5.0 mm). C, This asymmetrical pigmented nodule has a blue-white veil, multiple brown dots (white
arrows), 5 or 6 colors, peripheral black dots and globules, milky red and pink areas, and irregular blotches (Breslow thickness, 6.7 mm). D, This asymmetrical
pigmented nodule has peripheral black dots and globules, irregular dots and globules (size and distribution), pseudopods (arrow), and black color (Breslow
thickness, 1.2 mm).
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A limitation of our study is the use of mixed photo-
graphic systems, most with incident light dermoscopy
devices but somewith cross-polarization. It is well docu-
mented that differences occur between these 2 methods
of dermoscopy,23with crystalline structures seen onlywith
the cross-polarized devices and comedolike openings
(crypts), milialike cysts, multiple blue-gray dots (granu-
larity), and blue-white veil less visualized comparedwith
conventional incident light devices. In our study, we did
not score dermoscopy features found exclusively with
cross-polarized devices (crystalline structures).
We tested a modified first-step dermoscopy proce-
dure (that included vascular structures) aimed at defin-
ing melanocytic from nonmelanocytic lesions. The re-
sults differed for pigmented compared with amelanotic/
hypomelanotic lesions. For pigmented lesions, themethod
showed a very high sensitivity for both NM and non-
nodular invasive melanoma (98%) and a high sensi-
tivity for benign nodularmelanocytic lesions (95%).How-
ever, the specificity was significantly less (62%). In
principle, this results in overcalling nodular lesions as
melanocytic, which in practice leads the clinician to con-
sider the diagnosis of NM more frequently. We believe
this is beneficial to decrease the misdiagnosis of NM.
In contrast, the modified first-step method, as previ-
ously reportedwith the original first-stepmethod,7 did not
achieve an adequate sensitivity for detecting amelanotic/
hypomelanotic nodular lesions as being trulymelanocytic
(84%NM, 88%benign lesions). Nevertheless, in both pig-
mented and light-colored lesions, of the12melanomasmis-
classified as nonmelanocytic with the modified first-step
dermoscopy method, 11 had features of basal cell carci-
noma and hence would have been excised.
As previously described,7 light-colored lesions are best
distinguished asmalignant vs benign rather than attempt-
ing to differentiate within malignant subtypes. We con-
firmed this, with the previously reportedmethod achiev-
ing a high sensitivity for the diagnosis of amelanotic/
hypomelanotic NM in our study.
We tested a variety of second-step methods previ-
ously described for the diagnosis of pigmented mela-





Figure 3. Symmetrical pigmented nodular melanoma. Although most nodular pigmented melanoma lesions have asymmetrical pigmented patterns, 5.8% have
symmetrical pigmentation, as seen here. The Breslow thicknesses are A, 1.7 mm; B, 1.0 mm; C, 0.9 mm; and D, 4.3 mm.
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ers were assigned to each method, with these scorers
having varying degrees of experience with their scoring
method. Hence, these results may differ if a larger group
of more- or less-experienced scorers is recruited. Nev-
ertheless, all methods tested showed a decrease in abso-
lute sensitivity with pigmented NM compared with non-
nodular invasive melanoma.
In conclusion, although theremaybe a bias in this study
toward lesions that were suspicious and hence photo-
graphed, most pigmented and hypomelanotic NM lesions
had dermoscopy features that allow their diagnosis. In the
pigmented variety, the clinician needs to be aware of the
small but significant number of lesions that have symme-
tryof patternunderdermoscopyexamination.Hence,when
a progressively growing, symmetrically patternedmelano-
cytic nodule is identified, the diagnosis of NMneeds to be
excluded. Indeed, we believe any nodular lesion that can-
not be confidently diagnosed as benign should be excised.
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